BJDX-Aktie erreicht 52-Wochen-Tief at 0.08 US-Dollar Von Investing.com

In one year for Bluejay Diagnostics, Inc. (BJDX), the Unternehmens company has fallen in about 52 weeks and is now trading at 0.08 US dollars. These young years may take a steep descent into a year, but the action will last a 1-year display of -99.68%. You can deal with the Besorgnis service, who is the BJDX-aktien kontinuierlich and Wert lost and quickly in the Vergleich zum Vorjahr einbüßten. The stark backwards mirror that broadens market trends and the possibilities of broader reform has never been better.

In other cases, Bluejay Diagnostics’ actions constitute an Aktienzusammenlegung (Reverse Stock Split). Die strategic Schritt diet darauf ab, de Handelsspreis voor de Action van de Stammkapitals van de Unternehmens zu erhöhen. The front of the Unternehmens contains the details of the representation of the Zusammenlegung festival. How Bluejay Diagnostics of the NASDAQ Stock Market has made an initial exploration, until 2025, the lesser stanforderungen and the stock markets will pass.

If you come to the second place that offers a part of the Satzung generation, the Quorum-Erfordernis voor Aktionaire Versammlungen van een Mehrheit op een Drittel of the stimulating Aktien is reduced. This transition is possible through the operation of the active action.

You can rely on one of the generated capitalizations and the extension of class C and D options. This provides additional flexibility for planning strategies and financing. Bluejay Diagnostics factory incurred a cost of US$8.75 million.

In the context of business operations, Frances Scally has followed the path of the interim financial chief, the chairman and CEO of the time, Neil Dey, his sister Verantwortlichkeiten as Hauptfinanz- and Rechnungslegungsbeauftragter übernommen hat. In the research into the power of Bluejay Diagnostics Fortschritte with the SYMON-I clinical trial, lately, the Messung von Interleukin-6 (IL-6) -Spiegeln of the hypersensitivity of patients in sepsis before they could develop.

InvestingPro Acknowledgment

Best Performance from Bluejay Diagnostics, Inc. (BJDX) stimulated more with the knowledge of InvestingPro. The active trading deal of 0.09 US dollars is on the 52 living day, which is sold in the article. InvestingPro data said that BJDX had a 1-Year-Preis-Gesamtrendite of -99.66%, the article showed significant changes from -99.68%.

InvestingPro Tips While BJDX is “expensive in terms of money” and “in the end, there is no profitable war”, the good performance of the action was very likely. The economics of the residents involved -9.05 million US dollars for the last two weeks of the quarter 2024, the financial situation was more light.

It is important to note that the BJDX “more Bargeld als Schulden in seiner Bilanz hält” and “liquid Mittel de kurzfristigen Verpflichtungen übersteigen”. This can offer the company certain financial flexibility when dealing with active debts.

Before you do any of the following analysis, give InvestingPro 13 other tips for BJDX, which reflects one of our other companies’ financial positions and market performance.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.